1A total of 92 patients were enrolled;95 were randomized to placebo, a nd 97 to Cere
While BPC-157, TB-500, KPV, and GHK-Cu injections have not been studied for safety and efficacy in large-scale human clinical trials, some risks may be hypothesized from their mechanisms of action
however, no significant changes were observed in LDL or total cholesterol.28 A 2022 meta-analysis focusing on adults with metabolic syndrome risk factors reached similar conclusions, noting modest reductions in LDL cholesterol and systolic blood pressure but overall marginal changes in total cholesterol.29 A broader 2024 review summarizing human and preclinical data suggests that astaxanthin may enhance insulin sensitivity and glucose uptake while supporting lipid metabolism and antioxidant balance, though these findings are based on limited trials and changes in biomarkers.30 These effects are thought to involve activation of Nrf2, a cellular pathway that turns on the bodys own antioxidant defenses, and improved mitochondrial energy metabolism, which may help regulate oxidative stress
For those patients, timing glutathione on days 46 post-injection in a fasting state is the protocol that consistently shows the best tolerance and lab marker improvement